7 results on '"Ed C Lavelle"'
Search Results
2. Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
- Author
-
Hugo Charles-Messance, Anna Wedderburn, Emer E. Hackett, Ed C. Lavelle, Mireille Ouimet, Joseph Keane, Natalia Muñoz-Wolf, Laura E. Gleeson, Frederick J. Sheedy, Seónadh O'Leary, Kathryn J. Moore, Daniel G.W. Johnston, Michelle A. Williams, Sinéad C. Corr, Sarah Case, Stephen V. Gordon, and Alicia Smyth
- Subjects
0301 basic medicine ,Phosphofructokinase-1 ,Interleukin-1beta ,Anti-Inflammatory Agents ,Article ,General Biochemistry, Genetics and Molecular Biology ,Mycobacterium tuberculosis ,Interferon-gamma ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,Interferon ,medicine ,Animals ,Humans ,Tuberculosis ,Macrophage ,Glycolysis ,Interferon gamma ,Psychological repression ,lcsh:QH301-705.5 ,Cell Proliferation ,Base Sequence ,biology ,Macrophages ,Macrophage Activation ,biology.organism_classification ,3. Good health ,Cell biology ,MicroRNAs ,HEK293 Cells ,RAW 264.7 Cells ,030104 developmental biology ,lcsh:Biology (General) ,Host-Pathogen Interactions ,030217 neurology & neurosurgery ,medicine.drug ,Phosphofructokinase - Abstract
Summary: Increased glycolytic metabolism recently emerged as an essential process driving host defense against Mycobacterium tuberculosis (Mtb), but little is known about how this process is regulated during infection. Here, we observe repression of host glycolysis in Mtb-infected macrophages, which is dependent on sustained upregulation of anti-inflammatory microRNA-21 (miR-21) by proliferating mycobacteria. The dampening of glycolysis by miR-21 is mediated through targeting of phosphofructokinase muscle (PFK-M) isoform at the committed step of glycolysis, which facilitates bacterial growth by limiting pro-inflammatory mediators, chiefly interleukin-1β (IL-1β). Unlike other glycolytic genes, PFK-M expression and activity is repressed during Mtb infection through miR-21-mediated regulation, while other less-active isoenzymes dominate. Notably, interferon-γ (IFN-γ), which drives Mtb host defense, inhibits miR-21 expression, forcing an isoenzyme switch in the PFK complex, augmenting PFK-M expression and macrophage glycolysis. These findings place the targeting of PFK-M by miR-21 as a key node controlling macrophage immunometabolic function. : Hackett et al. identify a role for the anti-inflammatory miR-21 in limiting host glycolysis during tuberculosis (TB) infection to favor bacterial replication. This occurs by targeting a pro-glycolytic isoform at the rate-limiting step in glycolysis, PFK-M, a process antagonized by the host Th1-cytokine IFN-γ, to promote full macrophage activation and antimicrobial function. Keywords: macrophage, metabolic reprogramming, tuberculosis, mycobacterium tuberculosis, glycolysis, microRNA, miR-21, interleukin-1b, phosphofructokinase, interferon gamma
- Published
- 2020
3. The Role of Inflammasomes in Adjuvant-Driven Humoral and Cellular Immune Responses
- Author
-
S. McCluskey, Ed C. Lavelle, and Natalia Muñoz-Wolf
- Subjects
0301 basic medicine ,medicine.medical_treatment ,Inflammasome ,Biology ,Acquired immune system ,Pyrin domain ,Proinflammatory cytokine ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Immune system ,Immunity ,030220 oncology & carcinogenesis ,Immunology ,Humoral immunity ,medicine ,Adjuvant ,medicine.drug - Abstract
Many adjuvants approved for human use and in clinical development activate multimeric protein scaffolds known as inflammasomes, which promote processing and secretion of the proinflammatory cytokines interleukin (IL)-1β and IL-18. The role of inflammasome-derived cytokines as orchestrators of innate responses is well documented, but their contribution to vaccine-induced adaptive immunity is less clear. Despite initial reports suggesting that alum salts, the most widely used adjuvants, required NACHT, leucine-rich repeat, and pyrin domain domains containing protein 3 (NLRP3) inflammasome activation to promote antigen-specific T helper 2 (Th2) responses and humoral immunity, it is now thought that these responses are NLRP3 independent with contributions from a number of other factors including host DNA. Recent evidence implicates inflammasome-dependent cytokines in adjuvant-induced cell-mediated immunity, particularly Th1 and Th17 responses, and immunological memory. This provides a strong rationale for the development of inflammasome-targeting adjuvants. Understanding how inflammasome activation modulates vaccine-induced cell-mediated immunity and immunological memory and how this can be exploited by adjuvants is a productive research direction to enhance the development of next-generation vaccines.
- Published
- 2017
- Full Text
- View/download PDF
4. Adjuvant Strategies for Vaccines
- Author
-
Ed C. Lavelle and Claire H. Hearnden
- Subjects
business.industry ,medicine.medical_treatment ,Immunology ,medicine ,Cancer ,Cancer vaccine ,medicine.disease ,business ,Adjuvant ,health care economics and organizations ,humanities - Abstract
This chapter describes the types of adjuvants that are being investigated as potential cancer adjuvant candidates and those that are currently being used in vaccines against certain cancers.
- Published
- 2013
- Full Text
- View/download PDF
5. List of Contributors
- Author
-
Paola Allavena, Maria Libera Ascierto, Davide Bedognetti, Daniel W. Beury, Vincenzo Bronte, Sjoerd H. van der Burg, Zheng Cai, Margaret K. Callahan, Bruce D. Car, Gang Chen, Mariacristina Chioda, Olesya Chornoguz, Sandra Demaria, Jiehui Deng, Julie Y. Djeu, Sarah S. Donatelli, Charles G. Drake, Glenn Dranoff, Nicholas M. Durham, Laurence C. Eisenlohr, Leisha A. Emens, Benedetto Farsaci, Taylor Feehley, Paola Filipazzi, Maria Rosaria Galdiero, Gianfranco di Genova, Paul B. Gilman, Mark I. Greene, John W. Greiner, James L. Gulley, Claire Hearnden, James W. Hodge, Veronica Huber, Elizabeth M. Jaffee, Masahisa Jinushi, Richard Jove, Michael H. Kershaw, Robert Kiss, Ilona Kryczek, Richard A. Lake, Bradley W. Lash, Ed C. Lavelle, W. Joost Lesterhuis, Charles J. Link, Jing Liu, Nancy Luckashenak, Ravi A. Madan, Laura Mandik-Nayak, Susanna Mandruzzato, Alberto Mantovani, Ilaria Marigo, Francesco M. Marincola, Veronique Mathieu, Kenneth F. May, Andrew L. Mellor, Lauren M.F. Merlo, Richard Metz, Simone Mocellin, Richard A. Morgan, Alexander J. Muller, David H. Munn, Yasuhiro Nagai, Cathryn Nagler, Amanda Norvell, Anna K. Nowak, Takuya Ohtani, Suzanne Ostrand-Rosenberg, Christian H. Ottensmeier, Claudia Palena, Katherine H. Parker, Michael A. Postow, George C. Prendergast, Saul J. Priceman, Jenni Punt, Gabriel A. Rabinovich, W. Jay Ramsey, Licia Rivoltini, Gabriela R. Rossi, Eva Sahakian, Arabinda Samanta, Marimo Sato-Matsushita, Natalia Savelyeva, Jeffrey Schlom, Antonio Sica, Pratima Sinha, Courtney Smith, Mark J. Smyth, Eduardo M. Sotomayor, Freda K. Stevenson, Victoria Sundblad, Michele W.L. Teng, Kwong-Yok Tsang, Hiromichi Tsuchiya, Nicholas N. Vahanian, Alejandro Villagra, Ena Wang, Lin Wang, Shuang Wei, Marij J.P. Welters, Richard A. Westhouse, Karrune Woan, Jedd D. Wolchok, Hua Yu, Hongtao Zhang, Ende Zhao, Zhiqiang Zhu, and Weiping Zou
- Published
- 2013
- Full Text
- View/download PDF
6. Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
- Author
-
Emer E. Hackett, Hugo Charles-Messance, Seónadh M. O’Leary, Laura E. Gleeson, Natalia Muñoz-Wolf, Sarah Case, Anna Wedderburn, Daniel G.W. Johnston, Michelle A. Williams, Alicia Smyth, Mireille Ouimet, Kathryn J. Moore, Ed C. Lavelle, Sinéad C. Corr, Stephen V. Gordon, Joseph Keane, and Frederick J. Sheedy
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Summary: Increased glycolytic metabolism recently emerged as an essential process driving host defense against Mycobacterium tuberculosis (Mtb), but little is known about how this process is regulated during infection. Here, we observe repression of host glycolysis in Mtb-infected macrophages, which is dependent on sustained upregulation of anti-inflammatory microRNA-21 (miR-21) by proliferating mycobacteria. The dampening of glycolysis by miR-21 is mediated through targeting of phosphofructokinase muscle (PFK-M) isoform at the committed step of glycolysis, which facilitates bacterial growth by limiting pro-inflammatory mediators, chiefly interleukin-1β (IL-1β). Unlike other glycolytic genes, PFK-M expression and activity is repressed during Mtb infection through miR-21-mediated regulation, while other less-active isoenzymes dominate. Notably, interferon-γ (IFN-γ), which drives Mtb host defense, inhibits miR-21 expression, forcing an isoenzyme switch in the PFK complex, augmenting PFK-M expression and macrophage glycolysis. These findings place the targeting of PFK-M by miR-21 as a key node controlling macrophage immunometabolic function. : Hackett et al. identify a role for the anti-inflammatory miR-21 in limiting host glycolysis during tuberculosis (TB) infection to favor bacterial replication. This occurs by targeting a pro-glycolytic isoform at the rate-limiting step in glycolysis, PFK-M, a process antagonized by the host Th1-cytokine IFN-γ, to promote full macrophage activation and antimicrobial function. Keywords: macrophage, metabolic reprogramming, tuberculosis, mycobacterium tuberculosis, glycolysis, microRNA, miR-21, interleukin-1b, phosphofructokinase, interferon gamma
- Published
- 2020
- Full Text
- View/download PDF
7. Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing
- Author
-
Danielle M. Clancy, Graeme P. Sullivan, Hannah B.T. Moran, Conor M. Henry, Emer P. Reeves, Noel G. McElvaney, Ed C. Lavelle, and Seamus J. Martin
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Summary: Neutrophil granule proteases are thought to function as anti-microbial effectors, cooperatively hydrolyzing microorganisms within phagosomes, or upon deployment into the extracellular space. However, evidence also suggests that neutrophil proteases play an important role in the coordination and escalation of inflammatory reactions, but how this is achieved has been obscure. IL-1 family cytokines are important initiators of inflammation and are typically released via necrosis but require proteolytic processing for activation. Here, we show that proteases liberated from activated neutrophils can positively or negatively regulate the activity of six IL-1 family cytokines (IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ) with exquisite sensitivity. In contrast, extracellular neutrophil proteases displayed very poor bactericidal activity, exhibiting 100-fold greater potency toward cytokine processing than bacterial killing. Thus, in addition to their classical role as phagocytes, neutrophils play an important immunoregulatory role through deployment of their granule proteases into the extracellular space to process multiple IL-1 family cytokines. : Here, Clancy et al. show that proteases released by activated neutrophils into the extracellular space exhibited poor antimicrobial activity but were potent modulators of IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ activation states. Thus, neutrophils play a key role in modulating inflammatory responses through processing of multiple IL-1 family cytokines. Keywords: IL-1 family, inflammation, IL-33, IL-36, neutrophil, cathepsin G, elastase, cell death, necrosis, microbial killing
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.